Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is NF-κB predictive of biochemical recurrence in positive-margin prostate cancer?

Nature Clinical Practice Urology volume 2, pages 134–135 (2005)Cite this article

boxed-textFradet V et al. (2004) Nuclear factor-κB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer. Clin Cancer Res 10: 8460–8464

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Partin AW et al. (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localised prostate cancer. A multi-institutional update. JAMA 277: 1445–1451

    Article  CAS  Google Scholar 

  2. Kattan MW et al. (1999) Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17: 1499–1507

    Article  CAS  Google Scholar 

  3. Suh J et al. (2004) NF-κB activation in human prostate cancer: important mediator or epiphenomenon? J Cell Biochem 91: 100–117

    Article  CAS  Google Scholar 

  4. Kristiansen G et al. (2004) CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 58: 183–192

    Article  Google Scholar 

  5. Xu C et al. (2005) Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy. Prostate 62: 224–232

    Article  CAS  Google Scholar 

  6. Nelson PS (2004) Predicting prostate cancer behavior using transcript profiles. J Urol 172 (Suppl 5): S28–S32

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Michelmore, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Biomarkers of Prostate Cancer Group at the University Hospital Charité, Humboldt University Berlin,

    Carsten Stephan, Glen Kristiansen & Klaus Jung

  2. Department of Urology,

    Carsten Stephan, Glen Kristiansen & Klaus Jung

  3. Research Division,

    Carsten Stephan, Glen Kristiansen & Klaus Jung

  4. Pathological Institute and supervises the Immunohistochemical Laboratory,

    Carsten Stephan, Glen Kristiansen & Klaus Jung

Authors
  1. Carsten Stephan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Glen Kristiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Klaus Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Klaus Jung.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Glossary

PSA

Prostate-specific antigen

GLEASON SUM

Sum of grades assigned to the two largest cancerous areas of tissue samples; grades range from 1 (least aggressive) to 5 (most aggressive)

CI (CONFIDENCE INTERVAL)

An estimated range of values (based on a given set of sample data) that has a specified probability of containing the value being estimated

TUMOR STAGE

In the standard prostate cancer staging system, T stage refers to the degree of local extension. See also STAGE PT2–PT3

STAGE PT2–PT3

pT2 indicates a palpable nodule within the prostate, pT3 local extraprostatic extension, without (pT3a), or with (pT3b), invasion of the seminal vesicles

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stephan, C., Kristiansen, G. & Jung, K. Is NF-κB predictive of biochemical recurrence in positive-margin prostate cancer?. Nat Rev Urol 2, 134–135 (2005). https://doi.org/10.1038/ncpuro0119

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0119

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing